Budgeting for Opioid Addiction Treatment Act
- Last Action
- 5/20/2021
Actions
- 2021-05-20Read twice and referred to the Committee on Finance.
- 2021-05-20Introduced in Senate
CRS Summary
As of 2021-05-20 (00)
Budgeting for Opioid Addiction Treatment Act
This bill imposes an excise tax on the sale of any active opioid. The tax is equal to one cent per milligram so sold and it is imposed on the manufacturer, producer, or importer of the opioid. The term active opioid means any controlled substance that is opium, an opiate, or any derivative thereof.
The bill provides block grants for substance abuse treatment programs.
The Department of Health and Human Services must report on the impact of this bill on (1) the retail cost of active opioids; (2) patient access to such opioids, particularly cancer and hospice patients; and (3) the use of tax revenues to improve substance abuse treatment efforts. The report must also make suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.
Cosponsors (10)
- Mitt Romney (R-UT)
- Amy Klobuchar (D-MN)
- Tammy Baldwin (D-WI)
- Angus King (I-ME)
- Elizabeth Warren (D-MA)
- Jeanne Shaheen (D-NH)
- Maggie Hassan (D-NH)
- Richard Blumenthal (D-CT)
- Tina Smith (D-MN)
- Sheldon Whitehouse (D-RI)
Subjects
- Cancer
- Congressional oversight
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Health care coverage and access
- Health programs administration and funding
- Health promotion and preventive care
- Long-term, rehabilitative, and terminal care
- Prescription drugs
- Sales and excise taxes
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.